Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
New type of dementia is ‘100 times more common’ than ALS

New type of dementia is ‘100 times more common’ than ALS

Physicians have defined a new form of dementia that may be more common than Alzheimer’s disease. The findings were published in the latest issue of the journal Brain and involved researchers from around the world, including the United States, Australia, Austria, Sweden, Japan, and the United Kingdom.

Physicians have defined a new form of dementia that may be more common than Alzheimer’s disease.Semnic | Shutterstock

The researchers have named the new condition “LATE”, which stands for “Limbic-predominant age-related TDP-43 encephalopathy”. LATE is slower to progress than Alzheimer’s disease, but the two conditions show similar symptoms. There may, however, be further, undiscovered effects of LATE on the brain compared to Alzheimer’s disease.

The team explain that in some persons both conditions may coexist. In these individuals, there may be a faster and more marked decline in the cognitive abilities than when either of the conditions are present in isolation.

‘Overhauling the concept of dementia’

The paper says that the newly defined condition is speculated to have “an expanding but under-recognized impact on public health.” The team hopes that this study would spur research looking into this disease that generally affects people aged 80 and above.

Lead author Dr. Peter Nelson, director of neuropathology at the University of Kentucky Medical Center said, “We’re really overhauling the concept of what dementia is.”

The researchers explain that the disease and its diagnosis did not appear suddenly. Instead, evidence has been building up for many years. There were always cases and reports that described symptoms which did not fit into any of the known types of dementia, with experts saying that no single form of dementia could explain certain symptoms. While some people lost their language abilities first, others lost their memories and experienced personality changes instead.

LATE affects the limbic area of the brain, through a protein TDP-43. Protein misfolding is not uncommon in neurodegenerative diseases, as emphasized by the involvement of the protein’s tau and amyloid in Alzheimer’s disease.

In LATE, TDP-43 is misfolded and modified. It is most commonly observed in regions where Alzheimer’s-associated proteins are not found. Experts say that the protein itself, as well as its location, is what defines the condition as different to Alzheimer’s and other forms of dementia.

‘The whole elephant’

TDP is known to be implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). This association has been established for a decade now.

Dr. Peter Nelson says that LATE is a “disease that’s 100 times more common than [ALS or FTLD), and nobody knows about it.” The authors speculate that around 20 to 50 percent of the people aged over 80 years have significant brain changes that are associated with LATE, and the prevalence of this condition rises with age.

People have, in their own separate bailiwicks, found different parts of the elephant. But this is the first place where everybody gets together and says, ‘This is the whole elephant.’”

Dr. Peter Nelson

Up until now, clinical trials for drugs against Alzheimer’s disease have shown little to no success. This could be because a sizable portion of the participants could be suffering from LATE rather than Alzheimer’s disease.

Recent research and clinical trials in Alzheimer’s disease have taught us two things: First, not all of the people we thought had Alzheimer’s have it; second, it is very important to understand the other contributors to dementia.”

Nina Silverberg from the National Institute on Aging

However, opinion on this matter is divided: “I’m sure it plays some part, but maybe not as much as one might think at first,” said Silverberg.

“We could go back and screen all the people that had failed their Alzheimer’s disease therapies. But what we really need to do is go forward and try to get these people out of the Alzheimer’s clinical trials – and instead get them into their own clinical trials,” said Nelson.

The new study could act as a roadmap in research in dementia, but this is not likely to happen soon: “It’s probably going to take years and research participants to help us understand all of that,” said Silverberg.

Promoting awareness

Authors have identified five genes that increase the risk of LATE. These include, “LATE-NC: GRN, TMEM106B, ABCC9, KCNMB2, and APOE.” The pathogenetic mechanisms associated with LATE are similar to that of “frontotemporal lobar degeneration and Alzheimer’s disease.”

It is now hoped that the study will pave the way for research into late, with the authors encouraging awareness: “It is important to promote awareness in multiple scientific areas and to focus on translational and interdisciplinary approaches.”

What is TDP-43?

TDP-43, also known as “transactive response DNA binding protein of 43 kDa”, is a protein that usually helps in regulation of gene expression in the brain and other tissues. Recent studies have revealed that misfolded forms of this protein can be found in as many as 25% of adults over 85 years of age. Misfolding of TDP-43 leads to alterations in memory and cognitive abilities, much like Alzheimer’s and dementia.

When looking at TDP-43 aggregates (clumps), the team noted that it was present either only at the amygdala region of the brain (Stage 1 LATE), in the amygdala and the hippocampus (Stage 2 of LATE) or in the amygdala, hippocampus and middle frontal gyrus (Stage 3 of LATE).

The hippocampus is the area of the brain responsible for memory and learning. Misfolded TDP-43 protein has been seen to cause sclerosis or hardening and cell death in the reason of the hippocampus. This is accompanied by hippocampal shrinking. This pathology is associated with AD.

Alzheimer’s Disease-Related Dementias (ADRD) Summit 2019 will soon take place, where it is almost certain that LATE and TDP-43 will feature as an emerging topic of interest.

Tagged with:

About author

Related Articles